Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women (Q35177631)

6 August 2017

1 reference

title

Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women (English)

1 reference

6 August 2017

1

Jacob Gilad

1 reference

6 August 2017

Asnat Walfisch

2

1 reference

6 August 2017

Abraham Borer

series ordinal

3

1 reference

6 August 2017

Francisc Schlaeffer

series ordinal

4

1 reference

6 August 2017

publication date

1 August 2003

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

6 August 2017

published in

1 reference

6 August 2017

volume

109

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

199-205

1 reference

Trends in heterosexually acquired AIDS in the United States, 1988 through 1995.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

HIV prevalence in pregnant women in Europe: differences in assessment methods and prevalence levels across countries

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Prevalence of HIV-1 among attenders at sexually transmitted disease clinics: analyses according to country of birth

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Characteristics of pregnant HIV-1 infected women in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Women, drugs and HIV/AIDS: results of a multicentre European study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

HIV viral load markers in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Measurement of plasma HIV viral load--clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Sex differences in HIV-1 viral load and progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Sex differences in HIV-1 viral load and progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Sex differences in HIV-1 viral load and progression to AIDS. ICONA Study Group. Italian cohort of HIV-1 positive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

HIV viral load in Thai men and women with subtype E infections

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Gender differences in human immunodeficiency virus-related oral lesions: an Italian study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Epidemiology of HIV-related oral manifestations in women: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Treatment of epidemic (AIDS-related) Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

AIDS-related malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Kaposi's sarcoma and its management in AIDS patients. Recommendations from a Scandinavian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

HIV transmission and Kaposi's sarcoma among European women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

AIDS-Associated Kaposi's Sarcoma Is More Aggressive in Women: A Study of 54 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Lack of behavioural risk factors for squamous intraepithelial lesions (SIL) in HIV-infected women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Is HIV infection associated with an increase in the prevalence of cervical neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

The cellular response associated with cervical intraepithelial neoplasia in HIV+ and HIV- subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Management of cervical neoplasia in human immunodeficiency virus-infected women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Utilization of healthcare services by people living with HIV/AIDS in Europe. Eurosupport Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Gynecological neoplasias in the patient with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Vaginal infections in human immunodeficiency virus-infected women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Influence of human immunodeficiency virus infection on pelvic inflammatory disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Gender differences in virologic response to treatment in an HIV-positive population: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Gender differences in perceived health-related quality of life among patients with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900048-4

7 January 2021

10.1016/S0301-2115(03)00048-4

Identifiers

DOI

1 reference

6 August 2017

1 reference